EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study

Valeria Zuccalà iD, Nicoletta Staropoli, Caterina Labanca, Gabriele Ricciardi iD, Pietro Tralongo iD, Vincenzo Fiorentino iD, Elisabetta Procopio, Maria Renne, Antonio Ieni, Maurizio Martini iD, Pierfrancesco Tassone iD, Pierosandro Tagliaferri

Diseases · 03.10.2026 · 14 (10) · 367

DOI: 10.3390/diseases14100367 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diseases, online erschienen am 03.10.2026. Verfasst von Valeria Zuccalà und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, Department of Human Pathology of Adults and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: We examined combinations of immune- and stromal-associated features in pretreatment triple-negative breast cancer (TNBC) biopsies and explored their clinical and germline associations.

Methods

This retrospective study included 24 women with nonmetastatic TNBC from a clinically selected BRCA1/BRCA2-tested cohort. Two pathologists, blinded to clinical and germline data, jointly assessed stromal tumor-infiltrating lymphocytes (sTILs), programmed death-ligand 1 (PD-L1), CD68/CD163-positive macrophages, and CD117/tryptase-positive mast cells. Profiles were assigned before unblinding. A second blinded joint sTIL assessment provided continuous estimates for subsequent hierarchical clustering; profile assignments remained unchanged.

Results

Profiles I–III comprised seven, 13, and four tumors, respectively. Profile I combined higher sTILs and PD-L1 with a CD68-high/CD163-low pattern and rare mast cells. Profile II showed lower sTILs and PD-L1, a CD68-low/CD163-high pattern, and dense mast-cell hotspots; Profile III had minimal sTILs, low macrophage counts, and no mast cells detected in evaluated fields. Clustering reproduced these assignments. All four patients with pathogenic/likely pathogenic germline BRCA1/BRCA2 variants were in Profile I (adjusted p = 0.030); omitting one positive case at a time increased the adjusted p value to 0.068. Seven of 16 neoadjuvant-treated patients achieved pathologic complete response. Five posttreatment recurrences and seven deaths were recorded; exploratory comparisons of pathologic complete response and overall survival were inconclusive.

Conclusions

These profiles describe different combinations of lymphocytic infiltration, PD-L1 expression, macrophage counts, and mast-cell hotspots. The profiles and the exploratory BRCA1/BRCA2 finding require validation in larger, independent cohorts before clinical use.

Schlagwörter

Stichwörter der Autor:innen

PD-L1androgen receptorgermline BRCA1/BRCA2hierarchical clusteringmast cellsstromal tumor-infiltrating lymphocytestissue-context profiletriple-negative breast cancertumor-associated macrophages

Autor:innen und Institutionen

  • Division of Pathology, Department of Human Pathology of Adults and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
  • Medical Oncology Unit, "R. Dulbecco" Teaching Hospital (Mater Domini Facility), Magna Græcia University and Cancer Center, Campus Salvatore Venuta, 88100 Catanzaro, Italy.
  • Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, 88100 Catanzaro, Italy.
  • Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, 98125 Messina, Italy.
  • Pathology Unit, "Renato Dulbecco" Hospital, 88100 Catanzaro, Italy.
  • Surgery Unit, "R. Dulbecco" Teaching Hospital (Mater Domini Facility), Magna Græcia University and Cancer Center, Campus Salvatore Venuta, 88100 Catanzaro, Italy.

ORCID-Profile: Valeria Zuccalà, Gabriele Ricciardi, Pietro Tralongo, Vincenzo Fiorentino, Maurizio Martini, Pierfrancesco Tassone

Zitieren

APA

Zuccalà, V., Staropoli, N., Labanca, C., Ricciardi, G., Tralongo, P., Fiorentino, V., Procopio, E., Renne, M., Ieni, A., Martini, M., Tassone, P., & Tagliaferri, P. (2026). Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study. Diseases, 14(10), 367. https://doi.org/10.3390/diseases14100367

Vancouver

Zuccalà V, Staropoli N, Labanca C, Ricciardi G, Tralongo P, Fiorentino V, et al. Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study. Diseases. 2026;14(10):367. doi:10.3390/diseases14100367

BibTeX
@article{Zuccal2026,
  author = {Zuccalà, Valeria and Staropoli, Nicoletta and Labanca, Caterina and Ricciardi, Gabriele and Tralongo, Pietro and Fiorentino, Vincenzo and Procopio, Elisabetta and Renne, Maria and Ieni, Antonio and Martini, Maurizio and Tassone, Pierfrancesco and Tagliaferri, Pierosandro},
  title = {Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study},
  journal = {Diseases},
  year = {2026},
  volume = {14},
  number = {10},
  pages = {367},
  doi = {10.3390/diseases14100367}
}
Kostenlos starten →